`

DMK Pharmaceuticals Corporation

Pharmaceutical Manufacturing

revenue-icon Revenue
11M - 100M
funding-icon Total Funding
--
size-icon Size
11 - 50

Frequently Asked Questions About DMK Pharmaceuticals Corporation

What does Dmk pharmaceuticals corporation do?+

DMK Pharmaceuticals (NASDAQ: DMK) is a commercial stage neuro-biotech company primarily focused on developing and commercializing products for the treatment of opioid overdose and substance use disorders.The commercially approved products include ZIMHI (naloxone) and SYMJEPI. ZIMHI (naloxone) Injection is FDA approved for opioid overdose emergency rescue. SYMJEPI (epinephrine) Injection is FDA approved for use in the emergency treatment of acute allergic reactions, including anaphylaxis

What is Dmk pharmaceuticals corporation's industry? +

Dmk pharmaceuticals corporation operates in the Pharmaceutical manufacturing industry.

What is Dmk pharmaceuticals corporation's revenue? +

Dmk pharmaceuticals corporation's revenue is 11m - 100m

What is Dmk pharmaceuticals corporation's company size? +

Dmk pharmaceuticals corporation has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.